These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32492783)

  • 1. Conversion from Standard-Release Tacrolimus to MeltDose
    von Einsiedel J; Thölking G; Wilms C; Vorona E; Bokemeyer A; Schmidt HH; Kabar I; Hüsing-Kabar A
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32492783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Kidney Allograft Function after Early Conversion of Fast IR-Tac Metabolizers to LCP-Tac.
    Thölking G; Tosun-Koç F; Jehn U; Koch R; Pavenstädt H; Suwelack B; Reuter S
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
    Rostaing L; Bunnapradist S; Grinyó JM; Ciechanowski K; Denny JE; Silva HT; Budde K;
    Am J Kidney Dis; 2016 Apr; 67(4):648-59. PubMed ID: 26717860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Administration of Once-Daily MeltDose
    Willuweit K; Frey A; Hörster A; Saner F; Herzer K
    J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33396492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of switching from twice-daily tacrolimus to once-daily extended-release meltdose tacrolimus on cellular immune response.
    Anft M; Zgoura P; Skrzypczyk S; Dürr M; Viebahn R; Westhoff TH; Stervbo U; Babel N
    Front Transplant; 2024; 3():1405070. PubMed ID: 39386200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Switching From Immediate- or Prolonged-Release to Once-Daily Extended-Release Tacrolimus (LCPT) on Tremor in Stable Kidney Transplant Recipients: The Observational ELIT Study.
    Giral M; Grimbert P; Morin B; Bouvier N; Buchler M; Dantal J; Garrigue V; Bertrand D; Kamar N; Malvezzi P; Moreau K; Athea Y; Le Meur Y
    Transpl Int; 2024; 37():11571. PubMed ID: 38694490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in
    Budde K; Rostaing L; Maggiore U; Piotti G; Surace D; Geraci S; Procaccianti C; Nicolini G; Witzke O; Kamar N; Albano L; Büchler M; Pascual J; Gutiérrez-Dalmau A; Kuypers D; Wekerle T; Głyda M; Carmellini M; Tisone G; Midtvedt K; Wennberg L; Grinyó JM
    Transpl Int; 2022; 35():10225. PubMed ID: 36017158
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness and safety of the conversion to MeltDose
    Sánchez Fructuoso A; Ruiz JC; Franco A; Diekmann F; Redondo D; Calviño J; Serra N; Aladrén MJ; Cigarrán S; Manonelles A; Ramos A; Gómez G; González Posada JM; Andrés A; Beneyto I; Muñiz AL; Perelló M; Lauzurica R
    Clin Transplant; 2020 Jan; 34(1):e13767. PubMed ID: 31815310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-release tacrolimus dosing and outcomes in pediatric and young adult transplant recipients - A single-center experience.
    Huang X; Hapgood K; Allan K; Pruette C; Goswami E
    Pediatr Transplant; 2024 Feb; 28(1):e14611. PubMed ID: 37735900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.
    Kamar N; Cassuto E; Piotti G; Govoni M; Ciurlia G; Geraci S; Poli G; Nicolini G; Mariat C; Essig M; Malvezzi P; Le Meur Y; Garrigue V; Del Bello A; Rostaing L
    Adv Ther; 2019 Feb; 36(2):462-477. PubMed ID: 30552587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic Study of Conversion Between 2 Formulations of Once-daily Extended-release Tacrolimus in Stable Lung Transplant Patients.
    Sintes H; Sáez-Giménez B; Berastegui C; López-Meseguer M; Monforte V; Bravo C; Vima J; Gómez-Ollés S; Roman A
    Transplantation; 2018 Oct; 102(10):e439-e446. PubMed ID: 29965950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion From Immediate-Release to Prolonged-Release Tacrolimus in Kidney Transplant Patients With Tremor: A Case Series Study.
    Kamińska D; Hożejowski R; Chamienia A; Dębska-Ślizień A; Idasiak-Piechocka I; Oko A; Baranowicz-Gąszczyk I; Załuska W; Mazanowska O; Krajewska M
    Transplant Proc; 2024 May; 56(4):776-780. PubMed ID: 38453593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Envarsus XR® pharmacokinetics in adolescents post-kidney transplantation - A pilot study.
    ElChaki R; Ettenger R; Lee S; Chen L; Gales B; Srivastava R; Pearl M
    Pediatr Transplant; 2023 May; 27(3):e14480. PubMed ID: 36732080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability and costs of once-daily and twice-daily tacrolimus formulations in de novo kidney transplantation.
    Glander P; Waiser J; Kasbohm S; Friedersdorff F; Peters R; Rudolph B; Wu K; Budde K; Liefeldt L
    Clin Transplant; 2018 Aug; 32(8):e13311. PubMed ID: 29888809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early outcomes associated with de novo once-daily extended-release versus twice-daily immediate-release tacrolimus in a predominantly African American kidney transplant population: A single-center observational study.
    Romine MM; Leeser DB; Kennamer K; Nguyen C; Jones H; McLawhorn K; Kendrick S; Irish W
    Clin Transplant; 2024 Mar; 38(3):e15268. PubMed ID: 38450751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a novel tablet formulation of tacrolimus and conventional capsule formulation in
    Liu Z; Yin K; Liu H; Wang N; Yao J; Zhou J; Tang Y; Yin Z
    Front Pharmacol; 2023; 14():1310339. PubMed ID: 38143499
    [No Abstract]   [Full Text] [Related]  

  • 17. Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers After Renal Transplantation.
    Thölking G; Gillhaus NH; Schütte-Nütgen K; Pavenstädt H; Koch R; Suwelack B; Reuter S
    J Clin Med; 2020 Jan; 9(2):. PubMed ID: 31979381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MeltDose Technology vs Once-Daily Prolonged Release Tacrolimus in De Novo Liver Transplant Recipients.
    Baccarani U; Velkoski J; Pravisani R; Adani GL; Lorenzin D; Cherchi V; Falzone B; Baraldo M; Risaliti A
    Transplant Proc; 2019 Nov; 51(9):2971-2973. PubMed ID: 31607620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LCPT once-daily extended-release tacrolimus tablets versus twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroups.
    Bunnapradist S; Rostaing L; Alloway RR; West-Thielke P; Denny J; Mulgaonkar S; Budde K
    Transpl Int; 2016 May; 29(5):603-11. PubMed ID: 26953629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multi-Centre Non-Interventional Study to Assess the Tolerability and Effectiveness of Extended-Release Tacrolimus (LCPT) in De Novo Liver Transplant Patients.
    Soliman T; Gyoeri G; Salat A; Mejzlík V; Berlakovich G
    J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.